Latarsha Reid, Ph.D. - Publications
Affiliations: | 2011 | Pathobiology and Molecular Medicine | Columbia University, New York, NY |
Area:
Molecular Biology, GeneticsYear | Citation | Score | |||
---|---|---|---|---|---|
2011 | Shakya R, Reid LJ, Reczek CR, Cole F, Egli D, Lin CS, deRooij DG, Hirsch S, Ravi K, Hicks JB, Szabolcs M, Jasin M, Baer R, Ludwig T. BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity. Science (New York, N.Y.). 334: 525-8. PMID 22034435 DOI: 10.1126/Science.1209909 | 0.384 | |||
2009 | Szabolcs M, Keniry M, Simpson L, Reid LJ, Koujak S, Schiff SC, Davidian G, Licata S, Gruvberger-Saal S, Murty VV, Nandula S, Efstratiadis A, Kushner JA, White MF, Parsons R. Irs2 inactivation suppresses tumor progression in Pten+/- mice. The American Journal of Pathology. 174: 276-86. PMID 19095950 DOI: 10.2353/Ajpath.2009.080086 | 0.419 | |||
2008 | Reid LJ, Shakya R, Modi AP, Lokshin M, Cheng JT, Jasin M, Baer R, Ludwig T. E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks. Proceedings of the National Academy of Sciences of the United States of America. 105: 20876-81. PMID 19088202 DOI: 10.1073/Pnas.0811203106 | 0.383 | |||
Show low-probability matches. |